403 related articles for article (PubMed ID: 28985395)
1. Nonhuman Primates and Translational Research-Cardiovascular Disease.
Cox LA; Olivier M; Spradling-Reeves K; Karere GM; Comuzzie AG; VandeBerg JL
ILAR J; 2017 Dec; 58(2):235-250. PubMed ID: 28985395
[TBL] [Abstract][Full Text] [Related]
2. Nonhuman Primates and Translational Research: Progress, Opportunities, and Challenges.
Harding JD
ILAR J; 2017 Dec; 58(2):141-150. PubMed ID: 29253273
[TBL] [Abstract][Full Text] [Related]
3. Nonhuman primate models in translational regenerative medicine.
Daadi MM; Barberi T; Shi Q; Lanford RE
Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):83-7. PubMed ID: 25457970
[TBL] [Abstract][Full Text] [Related]
4. Effects of caloric restriction on cardiovascular aging in non-human primates and humans.
Cruzen C; Colman RJ
Clin Geriatr Med; 2009 Nov; 25(4):733-43, ix-x. PubMed ID: 19944270
[TBL] [Abstract][Full Text] [Related]
5. Nonhuman primate model in clinical modeling of diseases for stem cell therapy.
Choudhury GR; Kim J; Frost PA; Bastarrachea RA; Daadi MM
Brain Circ; 2016; 2(3):141-145. PubMed ID: 30276291
[TBL] [Abstract][Full Text] [Related]
6. Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.
Havel PJ; Kievit P; Comuzzie AG; Bremer AA
ILAR J; 2017 Dec; 58(2):251-268. PubMed ID: 29216341
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy in nonhuman primates.
Croll L; Szabo CA; Abou-Madi N; Devinsky O
Epilepsia; 2019 Aug; 60(8):1526-1538. PubMed ID: 31206636
[TBL] [Abstract][Full Text] [Related]
8. Baboons as a model to study genetics and epigenetics of human disease.
Cox LA; Comuzzie AG; Havill LM; Karere GM; Spradling KD; Mahaney MC; Nathanielsz PW; Nicolella DP; Shade RE; Voruganti S; VandeBerg JL
ILAR J; 2013; 54(2):106-21. PubMed ID: 24174436
[TBL] [Abstract][Full Text] [Related]
9. Primate stem cells: bridge the translation from basic research to clinic application.
Li T; Ai Z; Ji W
Sci China Life Sci; 2019 Jan; 62(1):12-21. PubMed ID: 30099707
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics: a tool to understand diet-related cardiovascular risk?
Zaina S; Lund G
J Nutrigenet Nutrigenomics; 2011; 4(5):261-74. PubMed ID: 22353663
[TBL] [Abstract][Full Text] [Related]
11. Why bother using non-human primate models of cognitive disorders in translational research?
Camus S; Ko WK; Pioli E; Bezard E
Neurobiol Learn Mem; 2015 Oct; 124():123-9. PubMed ID: 26135120
[TBL] [Abstract][Full Text] [Related]
12. Nutrigenomics in cardiovascular disease: implications for the future.
Engler MB
Prog Cardiovasc Nurs; 2009 Dec; 24(4):190-5. PubMed ID: 20002344
[TBL] [Abstract][Full Text] [Related]
13. Transgenic nonhuman primates for neurodegenerative diseases.
Chan AW
Reprod Biol Endocrinol; 2004 Jun; 2():39. PubMed ID: 15200672
[TBL] [Abstract][Full Text] [Related]
14. The unique value of primate models in translational research. Nonhuman primate models of women's health: introduction and overview.
Shively CA; Clarkson TB
Am J Primatol; 2009 Sep; 71(9):715-21. PubMed ID: 19507247
[TBL] [Abstract][Full Text] [Related]
15. Experimental primates and non-human primate (NHP) models of human diseases in China: current status and progress.
Zhang XL; Pang W; Hu XT; Li JL; Yao YG; Zheng YT
Dongwuxue Yanjiu; 2014 Nov; 35(6):447-64. PubMed ID: 25465081
[TBL] [Abstract][Full Text] [Related]
16. Genome typing of nonhuman primate models: implications for biomedical research.
Haus T; Ferguson B; Rogers J; Doxiadis G; Certa U; Rose NJ; Teepe R; Weinbauer GF; Roos C
Trends Genet; 2014 Nov; 30(11):482-7. PubMed ID: 24954183
[TBL] [Abstract][Full Text] [Related]
17. Utility of arterial blood gas, CBC, biochemistry and cardiac hormones as evaluation parameters of cardiovascular disease in nonhuman primates.
Nakayama S; Koie H; Kanayama K; Katakai Y; Ito-Fujishiro Y; Sankai T; Yasutomi Y; Ageyama N
J Vet Med Sci; 2018 Jul; 80(7):1165-1173. PubMed ID: 29887581
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Androgen Regulation of Metabolism in Nonhuman Primates.
True C; Abbott DH; Roberts CT; Varlamov O
Adv Exp Med Biol; 2017; 1043():559-574. PubMed ID: 29224110
[TBL] [Abstract][Full Text] [Related]
19. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics and cardiovascular disease.
Ordovás JM; Smith CE
Nat Rev Cardiol; 2010 Sep; 7(9):510-9. PubMed ID: 20603647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
